Advanced Ultrasound Contrast Agent Generation and Monitoring System

A next-generation system for producing and monitoring ultrasound contrast agents, leveraging advanced nanotechnology, machine learning, and real-time sensing to create more stable and tailored microspheres.

The original patent disclosed methods for preparing phospholipid-based ultrasound contrast agents, but these methods are limited by the susceptibility of phospholipid formulations to divalent metal cations. The new inventive concept addresses this limitation by introducing novel, calcium-resistant phospholipid variants, advanced nanotechnology-based blending, and real-time monitoring of precipitation.

The system comprises a microfluidic device for controlled phospholipid blending, a metal-ion-free chamber for minimizing precipitation, and a sensor array for detecting changes in solution conductivity. The system utilizes machine learning algorithms to predict optimal phospholipid blends and concentrations based on desired microsphere properties. The novel phospholipid composition is divalent-metal-cation-free, comprising a blend of synthetic, calcium-resistant phospholipid analogs and a proprietary solvent system for enhanced microsphere stability.

The new claims introduce a paradigm shift in ultrasound contrast agent generation and monitoring by incorporating advanced nanotechnology, machine learning, and real-time sensing. The use of novel, calcium-resistant phospholipid variants and metal-ion-free chambers provides a non-obvious solution to the problem of phospholipid precipitation.

Alternative embodiments may include variations in the microfluidic device design, different machine learning algorithms for phospholipid blend prediction, and modifications to the sensor array for detecting changes in solution conductivity. Additional variations may include the use of different solvent systems or phospholipid analogs.

The advanced ultrasound contrast agent generation and monitoring system has significant commercial potential in the medical imaging industry, particularly in the development of more effective and targeted ultrasound contrast agents for diagnostic and therapeutic applications.